48 Results
DEA Special Registration for Telemedicine
On January 15, the DEA released a proposed rule for special registration related to prescribing controlled substances via telemedicine when the prescribing practitioner has never conducted an in-person medical evaluation of the patient prior to the issuance of the prescription.
Congress, Federal Agencies Extend Pandemic Telehealth Flexibilities
Some key telehealth services will be extended until March 31, 2025, as part of the American Relief Act, signed by President Biden on December 21.
TEFCA Rule
The Trusted Exchange Framework and Common Agreement (TEFCA) final rule aims to facilitate the efficient, secure exchange of healthcare information across the care continuum.
Drug Enforcement Administration (DEA) and U.S. Department of Health and Human Services (HHS)Extend Telemedicine Flexibilities Through 2024
On November 15, 2024, the DEA in concert with HHS issued a third temporary extension of COVID-19 telehealth flexibilities for the prescribing of controlled medications.